Challenges of securing insurance approval for oral tofacitinib for the treatment of alopecia areata: a multi-institution retrospective review
Sign Up to like & getrecommendations! Published in 2021 at "Archives of Dermatological Research"
DOI: 10.1007/s00403-020-02158-y
Abstract: Alopecia areata (AA) is a psychologically distressing disorder for which few reliable treatments exist. Although oral tofacitinib has demonstrated efficacy in treating AA, it is not approved by the Food and Drug Administration (FDA) for… read more here.
Keywords: oral tofacitinib; tofacitinib; insurance approval; approval ... See more keywords